US Patent Application No: 2001/0049,350

GROWTH INHIBITION AND ERADICATION OF SOLID TUMORS USING NEUROENDOCRINE RESETTING THERAPY AND PHOTODYNAMIC THERAPY

Stats

Dec 6, 2001
Publication date
Nov 6, 1998
filing date
09/187,768
serial no
ABAN
status

Importance

Loading Importance Indicators... loading....

Abstract

A method of ablating the growth of or eradicating tumors in mammals having prolactin, growth hormone, and melatonin daily rhythms by adjusting one or more of the prolactin, growth hormone, and melatonin profiles of the mammal to conform to or approach the corresponding normal profile for healthy members of the same species and sex as said mammal, contacting the cells of the tumor with a photoactive photosensitizer, and, exposing the photosensitizer-contacted tumor cells to light of a predetermined wavelength, power density, and energy level.

Loading the Abstract Image... loading....

First Claim

loading....

Related Publications

Loading Related Publications... loading....

Patent Owner(s)

Patent Owner	Address	Total Patents
THE GENERAL HOSPITAL CORPORATION	BOSTON, MA, US	1312
PRESIDENT AND FELLOWS OF HARVARD COLLEGE	CAMBRIDGE, MA	1082

International Classification(s)

[Classification Symbol]

[Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Cincotta, Anthony H	Charlestown, MA	69	336
Cincotta, Louis	225 River Rd., Andover, MA 01810	38	152

Patent Citation Ranking

Forward Cites

No Forward Cites to Display

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Jun 6, 2013

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00